The BMJ: BioNTech Consultancy Sought to Undermine WHO Efforts to Create African mRNA Vaccine Tech Hub 10/02/2022 Editorial team A Maltese-based foundation representing BioNTech, the German company that co-produced with Pfizer a highly successful mRNA COVID vaccine, has been accused of seeking to undermine the World Health Organization’s new initiative to promote an open-source African-based COVID vaccine manufacturing hub – while proposing to ship European-fitted mRNA vaccine facilities to Africa in sea containers as […] Continue reading -> Global COVID Vacccine Campaign Asks for $16.8 Billion; Report Says 35% of Already Donated Doses Have Yet To Be Administered 09/02/2022 Paul Adepoju The WHO co-sponsored Act Accelerator Initiative, which aims to get 70% vaccine coverage to all countries by mid-2022, as well as more equal distribution of tests and treatments, tabled its latest ask to donors – for some $16.8 billion in new funds – out of what it says would be a total cost of $48 […] Continue reading -> Thirty African Countries Now Back Africa Medicines Agency Treaty But Continent’s Economic Powers Still Hold Out 03/02/2022 Paul Adepoju Some 21 countries have now ratified the African Medicines Agency treaty – well beyond the 15 ratifications reached in November 2021, which allowed the AMA treaty instrument to formally take effect. Egypt, Africa’s third most populous country, is the most recent state to have both ratified and deposited the treaty – marking a significant milestone […] Continue reading -> Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> ‘Vast Majority’ of Africans May Have Had Omicron; People Both Vaccinated & Infected Have the Best Immunity – IHME 27/01/2022 Elaine Ruth Fletcher Despite a severe lack of COVID test and serological data in Africa, most people on the continent have probably already been exposed to SARS-CoV2, said the director of the influential Institute for Health Metrics and Evaluation on Thursday. And in light of that, and the fact that COVID vaccines do not prevent infection, but rather […] Continue reading -> Delegates Agree to Tighten Pandemic Regulations, Get Reality Check from Civil Society 26/01/2022 Kerry Cullinan While three independent review panels concur that the response of the World Health Organization (WHO) to COVID-19 was inadequate, member states made slow progress in charting better alternatives at the executive board meeting on Wednesday. WHO members are considering three main proposals to improve the global body’s future pandemic preparedness: Setting up a Standing Committee […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global COVID Vacccine Campaign Asks for $16.8 Billion; Report Says 35% of Already Donated Doses Have Yet To Be Administered 09/02/2022 Paul Adepoju The WHO co-sponsored Act Accelerator Initiative, which aims to get 70% vaccine coverage to all countries by mid-2022, as well as more equal distribution of tests and treatments, tabled its latest ask to donors – for some $16.8 billion in new funds – out of what it says would be a total cost of $48 […] Continue reading -> Thirty African Countries Now Back Africa Medicines Agency Treaty But Continent’s Economic Powers Still Hold Out 03/02/2022 Paul Adepoju Some 21 countries have now ratified the African Medicines Agency treaty – well beyond the 15 ratifications reached in November 2021, which allowed the AMA treaty instrument to formally take effect. Egypt, Africa’s third most populous country, is the most recent state to have both ratified and deposited the treaty – marking a significant milestone […] Continue reading -> Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> ‘Vast Majority’ of Africans May Have Had Omicron; People Both Vaccinated & Infected Have the Best Immunity – IHME 27/01/2022 Elaine Ruth Fletcher Despite a severe lack of COVID test and serological data in Africa, most people on the continent have probably already been exposed to SARS-CoV2, said the director of the influential Institute for Health Metrics and Evaluation on Thursday. And in light of that, and the fact that COVID vaccines do not prevent infection, but rather […] Continue reading -> Delegates Agree to Tighten Pandemic Regulations, Get Reality Check from Civil Society 26/01/2022 Kerry Cullinan While three independent review panels concur that the response of the World Health Organization (WHO) to COVID-19 was inadequate, member states made slow progress in charting better alternatives at the executive board meeting on Wednesday. WHO members are considering three main proposals to improve the global body’s future pandemic preparedness: Setting up a Standing Committee […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Thirty African Countries Now Back Africa Medicines Agency Treaty But Continent’s Economic Powers Still Hold Out 03/02/2022 Paul Adepoju Some 21 countries have now ratified the African Medicines Agency treaty – well beyond the 15 ratifications reached in November 2021, which allowed the AMA treaty instrument to formally take effect. Egypt, Africa’s third most populous country, is the most recent state to have both ratified and deposited the treaty – marking a significant milestone […] Continue reading -> Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> ‘Vast Majority’ of Africans May Have Had Omicron; People Both Vaccinated & Infected Have the Best Immunity – IHME 27/01/2022 Elaine Ruth Fletcher Despite a severe lack of COVID test and serological data in Africa, most people on the continent have probably already been exposed to SARS-CoV2, said the director of the influential Institute for Health Metrics and Evaluation on Thursday. And in light of that, and the fact that COVID vaccines do not prevent infection, but rather […] Continue reading -> Delegates Agree to Tighten Pandemic Regulations, Get Reality Check from Civil Society 26/01/2022 Kerry Cullinan While three independent review panels concur that the response of the World Health Organization (WHO) to COVID-19 was inadequate, member states made slow progress in charting better alternatives at the executive board meeting on Wednesday. WHO members are considering three main proposals to improve the global body’s future pandemic preparedness: Setting up a Standing Committee […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> ‘Vast Majority’ of Africans May Have Had Omicron; People Both Vaccinated & Infected Have the Best Immunity – IHME 27/01/2022 Elaine Ruth Fletcher Despite a severe lack of COVID test and serological data in Africa, most people on the continent have probably already been exposed to SARS-CoV2, said the director of the influential Institute for Health Metrics and Evaluation on Thursday. And in light of that, and the fact that COVID vaccines do not prevent infection, but rather […] Continue reading -> Delegates Agree to Tighten Pandemic Regulations, Get Reality Check from Civil Society 26/01/2022 Kerry Cullinan While three independent review panels concur that the response of the World Health Organization (WHO) to COVID-19 was inadequate, member states made slow progress in charting better alternatives at the executive board meeting on Wednesday. WHO members are considering three main proposals to improve the global body’s future pandemic preparedness: Setting up a Standing Committee […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Vast Majority’ of Africans May Have Had Omicron; People Both Vaccinated & Infected Have the Best Immunity – IHME 27/01/2022 Elaine Ruth Fletcher Despite a severe lack of COVID test and serological data in Africa, most people on the continent have probably already been exposed to SARS-CoV2, said the director of the influential Institute for Health Metrics and Evaluation on Thursday. And in light of that, and the fact that COVID vaccines do not prevent infection, but rather […] Continue reading -> Delegates Agree to Tighten Pandemic Regulations, Get Reality Check from Civil Society 26/01/2022 Kerry Cullinan While three independent review panels concur that the response of the World Health Organization (WHO) to COVID-19 was inadequate, member states made slow progress in charting better alternatives at the executive board meeting on Wednesday. WHO members are considering three main proposals to improve the global body’s future pandemic preparedness: Setting up a Standing Committee […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Delegates Agree to Tighten Pandemic Regulations, Get Reality Check from Civil Society 26/01/2022 Kerry Cullinan While three independent review panels concur that the response of the World Health Organization (WHO) to COVID-19 was inadequate, member states made slow progress in charting better alternatives at the executive board meeting on Wednesday. WHO members are considering three main proposals to improve the global body’s future pandemic preparedness: Setting up a Standing Committee […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> Posts navigation Older postsNewer posts